Blog and Insights | RILA GLOBAL CONSULTING

Will AI Replace Analysts? Why the Future Belongs to AI-Native Talent

The analyst role is undergoing a seismic shift as AI redefines the skills that drive impact. While traditional “T-shaped” analysts relied on deep domain expertise and manual workflows, AI-native analysts harness intelligent agents to automate data prep, accelerate analysis, and orchestrate insights at unprecedented speed. This evolution demands mastery of prompt engineering, rigorous verification, and strategic business integration—transforming analysts from reactive report builders into proactive decision catalysts. In the agentic era, success belongs to those who don’t compete with AI, but conduct it, scaling human judgment and creativity across the enterprise.

AI Agent

Guided Insights, Evolved: How RILA’s AI Agents Are Transforming the Way We Understand Data

RILA GLOBAL CONSULTING is redefining guided insights with its advanced AI agents that move beyond static dashboards and surface-level analytics. Unlike traditional tools, these agents understand your questions in natural language, dynamically adapt to business context, investigate root causes, and deliver clear, actionable recommendations. By integrating seamlessly into workflows, they enable real-time decisions, reduce analyst overload, and empower every user to ask smarter questions and act faster. From uncovering the “why” behind KPI changes to triggering instant operational responses, RILA’s AI-powered guided insights transform data from passive reports into proactive, strategic business intelligence.

AI Agent

McDonald’s Consumer Sentiment in July 2025: AI, Price Concerns, and Service Quality

In July 2025, McDonald’s faced largely negative consumer sentiment across the U.S., driven by rising prices, perceived declines in quality, and concerns over AI integration in operations. Analysis of 1.28 million online conversations revealed that 18% discussed McDonald’s use of AI, with many questioning its impact on service speed, order accuracy, and personalized customer interaction. Price hikes without corresponding quality improvements fueled 28% of negative feedback, while smaller portions and operational issues—such as incorrect orders (25%) and cleanliness complaints (5%)—further hurt brand perception. Self-service kiosks sparked mixed reactions, with praise for convenience but frustration over customization errors. Despite innovations, consumers demand a balance between technological efficiency and consistent, human-centered service.

consumer insights

GDPR, HIPAA, and GVP VI: What to Look for in a Pharmacovigilance Research Partner

Choosing the right pharmacovigilance (PV) research partner is crucial due to the sensitive nature of safety data and stringent global regulations like GDPR, HIPAA, and GVP Module VI. Effective PV goes beyond adverse event detection—it requires secure, compliant, and audit-ready data handling. GDPR ensures data privacy in the EU, HIPAA safeguards health data in the U.S., and GVP VI governs PV reporting standards. A reliable PV partner must offer certified data security, robust compliance protocols, and proven experience with global pharmaceutical clients. RILA GLOBAL CONSULTING exemplifies this with comprehensive, compliance-first PV research solutions that protect both patients and reputations.

SOC 2 and ISO in Pharma Research: Why Security Matters in Pharmacovigilance Projects

In pharmaceutical research and pharmacovigilance (PV), data security is crucial for protecting sensitive patient and healthcare information, especially when dealing with real-world evidence and multi-source data. Certifications like SOC 2 Type II and ISO 27001 provide assurance that data integrity, secure access, and regulatory compliance are upheld throughout pharmacovigilance projects, from adverse event reporting to safety monitoring. These certifications help mitigate risks, support global regulatory standards, and ensure audit readiness. RILA GLOBAL CONSULTING exemplifies this security-first approach, offering encrypted data handling, compliant social listening, and global safety surveillance with built-in privacy and regulatory adherence.

How to Leverage Social Listening for Congress Research Submissions

In the pharmaceutical industry, social listening is emerging as a powerful tool for enhancing congress research submissions by providing real-world evidence (RWE) gathered from patient, caregiver, and healthcare professional conversations. When conducted in compliance with pharmacovigilance standards (e.g., GVP, GDPR, HIPAA), social listening helps pharma teams identify unmet needs, treatment patterns, and regional differences in therapy perceptions. By applying rigorous scientific analysis and medical validation, these insights can be transformed into congress-ready abstracts, posters, and presentations that align with specific congress objectives. RILA GLOBAL CONSULTING specializes in supporting this process through compliant data collection, multilingual analysis, and expert medical writing, helping pharma companies deliver impactful, patient-centric research at major congresses like ASCO, ESMO, and SABCS.

pharmaceutical marketing

Turning Real-World Conversations into Congress-Ready Research for Medical Affairs Teams

Medical Affairs teams are increasingly leveraging real-world conversations from patients, caregivers, and healthcare professionals—captured via social media and online communities—to supplement traditional clinical data. These insights, gathered through pharmacovigilance-compliant social listening and structured research, reveal unmet needs, treatment barriers, and patient experiences. With methodological rigor and regulatory compliance, this digital data is transformed into congress-ready abstracts, posters, and presentations, enhancing scientific communication and credibility. RILA GLOBAL CONSULTING supports this transformation, helping teams present accepted research at prestigious medical congresses like ASCO, ESMO, and SABCS, thereby elevating patient-centric strategies and cross-functional collaboration.

social media analytics

Adverse Event Detection Through Social Listening: A New Standard for Safety Teams

Adverse event (AE) detection in pharmacovigilance is being transformed by social listening, which enables safety teams to identify potential product safety issues in real-time by analyzing patient conversations on social media, forums, and blogs. Unlike traditional methods that often involve delayed reporting, social listening provides early signal detection, captures diverse patient experiences, and interprets symptoms in natural language. However, to be effective and compliant, AE detection via social listening must adhere to strict regulatory standards (e.g., GVP Module VI, GDPR, HIPAA) and use secure, validated workflows combining AI and human review. RILA GLOBAL CONSULTING leads in this space with globally compliant, AI-driven solutions that convert social data into actionable, ICSR-ready reports, helping pharmaceutical companies proactively manage risk and improve patient safety.

social listening

Pharmacovigilance-Compliant Social Media Monitoring: What Pharma Teams Need to Know

Social media monitoring has become essential for pharmacovigilance, enabling pharmaceutical companies to detect adverse events (AEs), product quality complaints (PQCs), and patient experiences in real time. To ensure regulatory compliance, safety teams must align monitoring practices with global pharmacovigilance regulations (e.g., GVP Module VI), data privacy laws (e.g., GDPR, HIPAA), and internal governance. Best practices include clear SOPs, team training, secure and certified platforms, integration of AI with human medical review, and meticulous documentation. RILA GLOBAL CONSULTING offers PV-compliant social media monitoring solutions, combining AI-driven detection, regulatory-aligned workflows, and multilingual capabilities to support global pharma teams in transforming social data into actionable insights.

data compliance

How Social Listening Is Revolutionizing Pharmacovigilance in the Life Sciences Industry

Social listening is revolutionizing pharmacovigilance by enabling life sciences companies to monitor real-time online conversations for early detection of adverse events (AEs) and safety trends. Unlike traditional safety monitoring methods that rely on delayed clinical and regulatory data, AI-powered social listening tools capture insights directly from patients, caregivers, and healthcare professionals across social media, forums, and blogs. This patient-centric, global approach enhances post-marketing surveillance, expands the reach of safety monitoring, and generates real-world evidence that meets high scientific standards. RILA GLOBAL CONSULTING offers compliant, secure, and efficient social listening workflows that transform digital mentions into actionable safety cases, positioning social listening as an essential component of modern pharmacovigilance strategies.

pharmaceutical marketing

Social Media and Pharmacovigilance: Opportunities, Challenges, and How RILA is Leading the Way

Social media is rapidly becoming a critical tool for pharmacovigilance (PV), offering pharmaceutical companies early insights into drug safety through real-world patient experiences. As AI and natural language processing evolve, social media will become an even more powerful tool in pharmacovigilance. With its proven track record, RILA GLOBAL CONSULTING is ready to help pharmaceutical teams transform raw social chatter into reliable, regulatory-compliant insights that protect patients and strengthen brand trust. RILA GLOBAL CONSULTING addresses these challenges by providing pharmacovigilance-compliant social listening, advanced data filtering using AI, and global compliance expertise. RILA not only ensures accurate and lawful data handling but also integrates social insights with traditional research methods to support drug safety monitoring, market research, and medical publications.

social media analytics

Transforming Pharmacovigilance Through Social Listening and Secure Research

RILA GLOBAL CONSULTING is revolutionizing pharmacovigilance by integrating social listening and secure, real-world research to uncover safety signals, patient needs, and actionable insights beyond traditional reporting methods. As a trusted partner to leading pharmaceutical companies, RILA offers pharmacovigilance-ready social data monitoring, robust data security (SOC 2 Type II, ISO 27001), and full compliance with GVP, GDPR, and HIPAA standards. Their AI-enhanced workflows support efficient case triage and medical review, while their global research capabilities span both qualitative and quantitative methodologies. RILA’s evidence-based findings have been accepted at major medical congresses, demonstrating their impact across Medical Affairs, Market Research, and beyond. With multilingual global teams and seamless collaboration across pharma functions, RILA delivers compliant, strategic insights throughout the drug lifecycle.

competitive intelligence

data compliance

From Turbulence to Techno-Optimism: What July 2025 Reveals About the Global Consumer Mindset

In July 2025, a sweeping analysis of 3.5 million social media posts revealed a striking snapshot of consumer psychology caught between economic strain and excitement for innovation. While inflation, trade policies, and housing affordability continued to drag down global and U.S. morale, bright spots emerged in travel and technology, where consumers voiced enthusiasm for AI-powered innovation such as AI assistants and health trackers. In housing and construction, consumers expressed fatigue with the home-buying process, high mortgage rates, and rising costs of construction materials. In retail, Gen Z consumers were vocal about affordable and discount-focused chains such as Aldi and Walmart, while healthcare discussions shifted toward wellness, preventative care and anxiety around China tariffs. Amid macroeconomic uncertainty, consumers are demanding value, transparency, utility and growing skepticism of traditional institutions. As consumers seek affordability without sacrificing experience, their expectations may signal a shift toward value-driven choices, and digital empowerment in the upcoming years.

social media analytics

customer insights

Personal Consumption Expenditures: What 170K Conversations Reveal About How Americans Are Spending

Between June 20 and June 27, 2025, over 170,000 online conversations revealed a widespread shift in American consumer behavior, with growing anxiety about personal consumption expenditures (PCE) due to inflation, labor market instability, and rising costs. Healthcare emerged as the top concern, dominating 25% of discussions, followed closely by cutbacks in discretionary spending like dining and entertainment. Gen Z reported a notable 13% drop in spending, driven by economic pressures including student debt and inflation. Sentiment analysis showed limited optimism, with only 2% of users expressing positive views focused on small business support and intentional purchases. Negative sentiment was fueled by fears around tariffs, oil prices, and AI-related job loss. Overall, consumers are prioritizing essential spending, with 73% expressing worry about declining PCE, signaling a cautious and value-driven financial mindset across the U.S.

social media analytics

customer insights

Non-US movies Tariff

Trump's proposed 100% tariff on non-U.S. films has sparked global outrage, with concerns over cultural isolationism, rising costs, and the impact on international cinema. The conversation is dominated by younger voices who view cinema as a global language, fearing this move will stifle diversity and collaboration in the film industry.

sentiment analysis

customer insights

consumer insights

MAHA Movement and U.S. Consumer Sentiment: Data-Driven Analysis of Online Reactions to the Synthetic Food Dye Ban

Analysis reveals significant online engagement regarding the synthetic food dye ban, with bipartisan support for health and safety concerns, particularly among parents. The MAHA movement has emerged as a key player, advocating for the removal of harmful dyes, with a notable positive sentiment from consumers.

social media analytics

sentiment analysis

Food Safety and Regulation

Watches, Status, and Screens: How Tech and Culture Are Shaping the Luxury Watch Market

Global consumer sentiment around luxury watches revealed a vibrant, evolving marketplace influenced by technology, gaming, and social narratives. While 43% of conversations reflected enthusiasm for innovative smartwatches like the Huawei Watch Fit 4, a more complex picture emerged through gaming crossovers, wellness features, and design admiration. Negative sentiment—though smaller—highlighted social controversies, tech overreach, and public scandals, demonstrating how deeply luxury timepieces are embedded in modern culture. Discussions ranged from the artistry of chronograph watches to the dominance of Rolex and the challenge of counterfeits, reflecting a space where prestige, digital engagement, and cultural relevance converge.

Walmart Faces Backlash as Tariff-Driven Price Hikes Dominate Online Conversation

Walmart experienced a major online backlash after announcing price hikes tied to new U.S. tariffs, with over 598,000 posts flooding social media—55.5% expressing dissatisfaction. Although initially boosted by a popular Megan Thee Stallion campaign, sentiment turned negative amid inflation concerns and political commentary from figures like Governor Kathy Hochul. Target continued to face fallout from its 2023 LGBTQ+ backlash, compounded by criticism of self-checkout issues and security practices, with over half of related posts being negative. Meanwhile, TJ Maxx retained strong consumer loyalty despite some operational complaints, bolstered by its value-driven focus and neutral political stance, especially on platforms like TikTok. As tariffs intensify, Walmart and Target grapple with image issues, while TJ Maxx benefits from brand trust and strategic diversification.

social media analytics

consumer insights

customer insights

Your destination for the latest trends, news, and consumer analyses

Will AI Replace Analysts? Why the Future Belongs to AI-Native Talent

Guided Insights, Evolved: How RILA’s AI Agents Are Transforming the Way We Understand Data

McDonald’s Consumer Sentiment in July 2025: AI, Price Concerns, and Service Quality

GDPR, HIPAA, and GVP VI: What to Look for in a Pharmacovigilance Research Partner

Will AI Replace Analysts? Why the Future Belongs to AI-Native Talent

Guided Insights, Evolved: How RILA’s AI Agents Are Transforming the Way We Understand Data

McDonald’s Consumer Sentiment in July 2025: AI, Price Concerns, and Service Quality

GDPR, HIPAA, and GVP VI: What to Look for in a Pharmacovigilance Research Partner

SOC 2 and ISO in Pharma Research: Why Security Matters in Pharmacovigilance Projects

How to Leverage Social Listening for Congress Research Submissions

Turning Real-World Conversations into Congress-Ready Research for Medical Affairs Teams

Adverse Event Detection Through Social Listening: A New Standard for Safety Teams

Pharmacovigilance-Compliant Social Media Monitoring: What Pharma Teams Need to Know

How Social Listening Is Revolutionizing Pharmacovigilance in the Life Sciences Industry

Social Media and Pharmacovigilance: Opportunities, Challenges, and How RILA is Leading the Way

Transforming Pharmacovigilance Through Social Listening and Secure Research

From Turbulence to Techno-Optimism: What July 2025 Reveals About the Global Consumer Mindset

Personal Consumption Expenditures: What 170K Conversations Reveal About How Americans Are Spending

Non-US movies Tariff

MAHA Movement and U.S. Consumer Sentiment: Data-Driven Analysis of Online Reactions to the Synthetic Food Dye Ban

Watches, Status, and Screens: How Tech and Culture Are Shaping the Luxury Watch Market

Walmart Faces Backlash as Tariff-Driven Price Hikes Dominate Online Conversation